• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大分割放疗有降低二次癌症发生的潜力。

Hypofractionated radiotherapy has the potential for second cancer reduction.

作者信息

Schneider Uwe, Besserer Jürgen, Mack Andreas

机构信息

Radiotherapy Hirslanden AG, Institute for Radiotherapy, Rain 34, Aarau, Switzerland.

出版信息

Theor Biol Med Model. 2010 Feb 11;7:4. doi: 10.1186/1742-4682-7-4.

DOI:10.1186/1742-4682-7-4
PMID:20149259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2829001/
Abstract

BACKGROUND AND PURPOSE

A model for carcinoma and sarcoma induction was used to study the dependence of carcinogenesis after radiotherapy on fractionation.

MATERIALS AND METHODS

A cancer induction model for radiotherapy doses including fractionation was used to model carcinoma and sarcoma induction after a radiation treatment. For different fractionation schemes the dose response relationships were obtained. Tumor induction was studied as a function of dose per fraction.

RESULTS

If it is assumed that the tumor is treated up to the same biologically equivalent dose it was found that large dose fractions could decrease second cancer induction. The risk decreases approximately linear with increasing fraction size and is more pronounced for sarcoma induction. Carcinoma induction decreases by around 10% per 1 Gy increase in fraction dose. Sarcoma risk is decreased by about 15% per 1 Gy increase in fractionation. It is also found that tissue which is irradiated using large dose fractions to dose levels lower than 10% of the target dose potentially develop less sarcomas when compared to tissues irradiated to all dose levels. This is not observed for carcinoma induction.

CONCLUSIONS

It was found that carcinoma as well as sarcoma risk decreases with increasing fractionation dose. The reduction of sarcoma risk is even more pronounced than carcinoma risk. Hypofractionation is potentially beneficial with regard to second cancer induction.

摘要

背景与目的

采用癌和肉瘤诱发模型研究放疗后致癌作用对分次照射的依赖性。

材料与方法

使用包含分次照射的放疗剂量致癌诱发模型来模拟放射治疗后癌和肉瘤的诱发情况。针对不同的分次照射方案,得出剂量反应关系。将肿瘤诱发作为每分次剂量的函数进行研究。

结果

如果假设肿瘤接受相同生物等效剂量的治疗,发现大剂量分次照射可降低二次癌症的诱发。风险随分次剂量增加大致呈线性降低,且在肉瘤诱发中更为明显。每分次剂量每增加1 Gy,癌诱发降低约10%。每分次照射增加1 Gy,肉瘤风险降低约15%。还发现,与照射至所有剂量水平的组织相比,使用大剂量分次照射至低于靶剂量10%剂量水平的组织潜在发生的肉瘤较少。癌诱发未观察到这种情况。

结论

发现癌和肉瘤风险均随分次剂量增加而降低。肉瘤风险的降低比癌风险更为明显。在二次癌症诱发方面,大分割放疗可能有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/237d31ac5a74/1742-4682-7-4-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/1b59b4766037/1742-4682-7-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/fbd8d3f3f929/1742-4682-7-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/208e5f8d8f2f/1742-4682-7-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/94b887e21041/1742-4682-7-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/237d31ac5a74/1742-4682-7-4-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/1b59b4766037/1742-4682-7-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/fbd8d3f3f929/1742-4682-7-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/208e5f8d8f2f/1742-4682-7-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/94b887e21041/1742-4682-7-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6476/2829001/237d31ac5a74/1742-4682-7-4-5.jpg

相似文献

1
Hypofractionated radiotherapy has the potential for second cancer reduction.大分割放疗有降低二次癌症发生的潜力。
Theor Biol Med Model. 2010 Feb 11;7:4. doi: 10.1186/1742-4682-7-4.
2
Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.现代切线野全乳腺照射的适形分割方案降低了心脏的分次剂量校正值。
Clin Oncol (R Coll Radiol). 2013 Mar;25(3):147-52. doi: 10.1016/j.clon.2012.07.012. Epub 2012 Aug 19.
3
What hypofractionated protocols should be tested for prostate cancer?前列腺癌应测试哪些大分割方案?
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1093-104. doi: 10.1016/s0360-3016(03)00132-9.
4
The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.高剂量率近距离放射治疗中的最佳分次剂量:取决于组织修复动力学和低剂量率。
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):844-9. doi: 10.1016/s0360-3016(01)02750-x.
5
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.同步整合加量调强放射治疗局部晚期头颈部鳞状细胞癌:II期临床结果
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87. doi: 10.1016/j.ijrobp.2004.03.010.
6
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.高剂量率(HDR)近距离放射治疗联合低分割外照射放疗治疗局限性前列腺癌后的急性泌尿生殖系统毒性:HDR近距离放射治疗中尿道剂量与急性泌尿生殖系统毒性严重程度之间的相关性
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71. doi: 10.1016/j.ijrobp.2004.11.041.
7
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌的比较:HYPO-RT-PC 随机、非劣效、III 期临床试验的 5 年结果。
Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18.
8
Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula.使用线性二次公式的分次放疗后辐射诱发癌症的机制模型。
Med Phys. 2009 Apr;36(4):1138-43. doi: 10.1118/1.3089792.
9
Radiation-induced second cancers: the impact of 3D-CRT and IMRT.放射诱导的二次癌症:三维适形放疗和调强放疗的影响
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8. doi: 10.1016/s0360-3016(03)00073-7.
10
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.原发性和转移性肺癌小体积、大分割、图像引导放射治疗中危及器官的耐受性
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):126-35. doi: 10.1016/s0360-3016(03)00095-6.

引用本文的文献

1
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).适形放疗时代前列腺癌放疗后发生第二原发恶性肿瘤的风险:德国放射肿瘤学会(DEGRO)前列腺癌工作组声明
Strahlenther Onkol. 2025 Jan;201(1):4-10. doi: 10.1007/s00066-024-02288-6. Epub 2024 Aug 28.
2
Assessment of Radiation-Induced Bladder and Bowel Cancer Risks after Conventionally and Hypo-Fractionated Radiotherapy for the Preoperative Management of Rectal Carcinoma.直肠癌术前常规和低分割放疗后放射性膀胱和肠癌风险评估
J Pers Med. 2022 Aug 31;12(9):1442. doi: 10.3390/jpm12091442.
3

本文引用的文献

1
Point/Counterpoint. Hypofractionation is a proven safe and effective modality for postoperative whole-breast radiotherapy for early breast cancer patients.针锋相对。对于早期乳腺癌患者,大分割放疗是术后全乳放疗一种经证实安全有效的方式。
Med Phys. 2009 Jun;36(6):1927-30. doi: 10.1118/1.3116462.
2
Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers.分剂量大小对肺部放射毒性的影响:对于肺癌的放疗增敏,低分割可能有益。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):782-8. doi: 10.1016/j.ijrobp.2009.02.079. Epub 2009 Jul 4.
3
Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.
Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost.
术后短疗程加速乳腺和淋巴结放疗(HypoAR)加量短疗程推量的长期结果。
Curr Oncol. 2021 Sep 7;28(5):3474-3487. doi: 10.3390/curroncol28050300.
4
Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution.前列腺癌患者现代外照射放疗的继发癌症风险:分割和剂量分布的影响。
J Radiat Res. 2021 Jul 10;62(4):707-717. doi: 10.1093/jrr/rrab038.
5
Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.质子颅脊放疗联合脊柱 spared 技术治疗儿童髓母细胞瘤时,终身归因于放射性二次癌症的风险影响。
J Radiat Res. 2021 Mar 10;62(2):186-197. doi: 10.1093/jrr/rraa118.
6
Cancer risk assessment in modern radiotherapy workflow with medical big data.基于医学大数据的现代放射治疗工作流程中的癌症风险评估
Cancer Manag Res. 2018 Jun 22;10:1665-1675. doi: 10.2147/CMAR.S164980. eCollection 2018.
7
Modelling recurrence and second cancer risks induced by proton therapy.质子治疗引发的复发和二次癌症风险建模。
Math Med Biol. 2018 Sep 11;35(3):347-361. doi: 10.1093/imammb/dqx006.
8
Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.直肠癌放疗后第二原发癌风险的评估:使用不同高剂量分割方案的三维适形放疗与容积调强弧形放疗的比较
Radiat Oncol. 2016 Nov 10;11(1):149. doi: 10.1186/s13014-016-0723-6.
9
Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.在随机抽样的儿科癌症患者中,质子束治疗与调强X线治疗相比,辐射诱发继发性癌症的终生归因风险。
J Radiat Res. 2017 May 1;58(3):363-371. doi: 10.1093/jrr/rrw088.
10
Radiotherapy and risks of tumor regrowth or inducing second cancer.放射治疗与肿瘤复发或诱发第二种癌症的风险。
Cancer Nanotechnol. 2011;2(1-6):81-93. doi: 10.1007/s12645-011-0018-4. Epub 2011 Aug 18.
局部前列腺癌的大分割放疗。临床试验综述
Clin Transl Oncol. 2009 Jul;11(7):437-45. doi: 10.1007/s12094-009-0382-2.
4
Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula.使用线性二次公式的分次放疗后辐射诱发癌症的机制模型。
Med Phys. 2009 Apr;36(4):1138-43. doi: 10.1118/1.3089792.
5
Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.大分割适形放疗与标准分割放疗治疗局限性前列腺癌的远期疗效:一项非随机当代对照研究
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1441-6. doi: 10.1016/j.ijrobp.2008.10.087. Epub 2009 Apr 22.
6
The ethics of hypofractionation for prostate cancer.前列腺癌大分割放疗的伦理学问题
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):969-70. doi: 10.1016/j.ijrobp.2008.11.022.
7
Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.我们能否降低放疗后发生第二原发性恶性肿瘤的发生率?一项批判性综述。
Radiother Oncol. 2009 Apr;91(1):4-15; discussion 1-3. doi: 10.1016/j.radonc.2008.12.016. Epub 2009 Feb 5.
8
Clinical experience using hypofractionated radiation schedules in breast cancer.乳腺癌中使用大分割放疗方案的临床经验。
Semin Radiat Oncol. 2008 Oct;18(4):257-64. doi: 10.1016/j.semradonc.2008.04.008.
9
Hypofractionation in radiotherapy for breast cancer.乳腺癌放疗中的大分割放疗
Lancet. 2008 Mar 29;371(9618):1050-2. doi: 10.1016/S0140-6736(08)60349-9. Epub 2008 Mar 19.
10
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.英国早期乳腺癌放疗超分割治疗标准化(START)试验B:一项随机试验
Lancet. 2008 Mar 29;371(9618):1098-107. doi: 10.1016/S0140-6736(08)60348-7. Epub 2008 Mar 19.